MEDIROM Healthcare Technologies Announces Acquisition of Japan Gene Medicine Corporation NEW YORK, July 10, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (“we”, “our”, “us” or “the Company”) hereby announces that the Company plans to acquire a majority of Japan Gene...

The first JAPAN IR Event 2024 was held at Nasdaq's U.S. headquarters TOKYO, July 01, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”), a holistic healthcare company based in Japan, announced that on June 20th...

MEDIROM Healthcare Technologies Inc. Announces Financial Results for Fiscal Year 2023 TOKYO, June 25, 2024 (GLOBE NEWSWIRE) --  MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“Medirom” or the “Company”), a holistic healthcare company based in Japan, announced it filed its Annual...

MEDIROM Healthcare Technologies Inc. Announces March 2024 Key Performance Indicators (KPIs) MEDIROM Healthcare Technologies Inc. Announces March 2024 Key Performance Indicators (KPIs)

MEDIROM Healthcare Technologies Inc. Files Its Annual Report on Form 20-F NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (“MEDIROM” or the “Company”), today announced it filed...